Summary
Definition
History and exam
Key diagnostic factors
- presence of risk factors
- diarrhoea
- abdominal pain
Other diagnostic factors
- fever
- abdominal tenderness
- nausea and vomiting
- abdominal distension
- symptoms of shock
Risk factors
- antibiotic exposure
- advanced age
- hospitalisation or residence in a nursing home
- exposure to infected family member
- history of Clostridioides difficile-associated disease
- use of acid-suppressing drugs
- inflammatory bowel disease
- solid organ transplant recipients
- haematopoietic stem cell transplant recipients
- chronic kidney disease
- HIV infection
- immunosuppressive agents or chemotherapy
- gastrointestinal surgery
- vitamin D deficiency
- consumption of C difficile contaminated food
Diagnostic investigations
1st investigations to order
- FBC
- stool guaiac (faecal occult blood test)
- stool polymerase chain reaction (PCR)
- stool immunoassay for glutamate dehydrogenase
- stool immunoassay for toxins A and B
- abdominal x-ray
Investigations to consider
- cell culture cytotoxicity neutralisation assay
- CT abdomen
- sigmoidoscopy or colonoscopy
Emerging tests
- stool lactoferrin or calprotectin
Treatment algorithm
initial episode: non-severe
initial episode: severe
initial episode: fulminant
first recurrence
subsequent recurrence
Contributors
Authors
Ali Hassoun, MD, FACP, FIDSA, AAHIVS
Clinical Associate Professor of Medicine
Alabama Infectious Diseases Center
Huntsville
AL
Disclosures
AH declares that he has no competing interests.
Peer reviewers
Gregory R. Madden, MD, MSDS
Assistant Professor
Division of Infectious Diseases and International Health
University of Virginia School of Medicine
Charlottesville
VA
Disclosures
GRM declares that he has no competing interests.
Satish Keshav, MBBCh, DPhil, FRCP
Consultant Gastroenterologist
Department of Gastroenterology
John Radcliffe Hospital
Oxford
UK
Disclosures
SK declares that he has no competing interests.
Ian Beales, MD, FRCP
Clinical Reader and Consultant Gastroenterologist
Norfolk and Norwich University Hospital
Norwich
UK
Declarações
IB declares that he has no competing interests.
Referências
Principais artigos
McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):e1-48.Texto completo Resumo
Johnson S, Lavergne V, Skinner AM, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021 Jun 24:ciab549.Texto completo Resumo
van Prehn J, Reigadas E, Vogelzang EH, et al. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect. 2021 Dec;27 Suppl 2:S1-S21.Texto completo Resumo
Nelson RL, Suda KJ, Evans CT. Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults. Cochrane Database Syst Rev. 2017;(3):CD004610.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Antibiotic-associated diarrhoea (AAD)
- Ischaemic colitis
- Bacterial or viral gastroenteritis
Mais Diagnósticos diferenciaisDiretrizes
- Clinical guidance for C. diff prevention in acute care facilities
- Clostridioides difficile infection: antimicrobial prescribing NICE guideline
Mais DiretrizesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal